Literature DB >> 9584953

Transgenic mice as research tools in neurocarcinogenesis.

U Rovigatti1, T Afanasyeva, S Brandner, J A Hainfellner, M Kiess, A Maddalena, G Malin, T Rülicke, J Steinbach, J Weissenberger, A Aguzzi.   

Abstract

Transgenic animal models for neurocarcinogenesis have provided significant insights into the molecular mechanisms underlying carcinogenic processes, including those which affect the nervous system. In view of the very rapid pace of acquisition of knowledge, it is not possible to cover all transgenic mouse models for neural tumors. Instead, this article discusses some of the most important technical innovations for manipulation of the mammalian genome (notably the various methods for targeted genome modifications, as well as the technology for introducing large DNA fragments into the germ line of mice), and presents a selection of the transgenic mouse models which are proving most promising for furthering our understanding of the pathogenetic basis of cancer in the nervous system.

Entities:  

Mesh:

Year:  1998        PMID: 9584953     DOI: 10.3109/13550289809114516

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  4 in total

1.  Mouse astrocytoma models: embryonic stem cell mediated transgenesis.

Authors:  H Ding; A Guha
Journal:  J Neurooncol       Date:  2001-07       Impact factor: 4.130

Review 2.  Angiogenesis in transgenic models of multistep carcinogenesis.

Authors:  M G D' Angelo; T Afanasieva; A Aguzzi
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

Review 3.  Molecular genetics of pineal region neoplasms.

Authors:  M D Taylor; T G Mainprize; J A Squire; J T Rutka
Journal:  J Neurooncol       Date:  2001-09       Impact factor: 4.130

4.  Advanced adult esthesioneuroblastoma successfully treated with cisplatin and etoposide alternated with doxorubicin, ifosfamide and vincristine.

Authors:  Salvatore Turano; Candida Mastroianni; Caterina Manfredi; Rosalbino Biamonte; Silvia Ceniti; Virginia Liguori; Rosanna De Simone; Serafino Conforti; Aldo Filice; Antonio Rovito; Caterina Viscomi; Giuseppe Patitucci; Salvatore Palazzo
Journal:  J Neurooncol       Date:  2009-11-19       Impact factor: 4.130

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.